Zydus gets zero USFDA observations for Ahmedabad animal health drug manufacturing facility
Ahmedabad: Through a recent BSE filing, Zydus Lifesciences Ltd. has informed that the US Food and Drug Administration (USFDA) has concluded the inspection with nil observations at the group’s animal health drug manufacturing facility at SEZ, Ahmedabad.
The inspection was conducted from 30th May to 2nd June, 2023.
Medical Dialogues team had earlier reported that the USFDA had concluded an inspection with three observations at Zydus Lifesciences's manufacturing facility SEZ-1 located at Pharmez, Ahmedabad.
Read also: USFDA issues 3 observations for Zydus Lifesciences Ahmedabad facility
Zydus Lifesciences Limited, Formerly known as Cadila Healthcare Limited, is an Indian Pharmaceutical company headquartered in Ahmedabad. The company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals. It is primarily engaged in the manufacture of generic drugs.
Read also: Zydus Lifesciences bags USFDA nod for hypotension injection Ephedrine Sulfate
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd